Principal Securities, Inc. Amicus Therapeutics, Inc. Transaction History
Principal Securities, Inc.
- $3.63 Trillion
- Q2 2024
A detailed history of Principal Securities, Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 532 shares of FOLD stock, worth $6,208. This represents 0.0% of its overall portfolio holdings.
Number of Shares
532
Previous 594
10.44%
Holding current value
$6,208
Previous $7 Million
24.58%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding FOLD
# of Institutions
279Shares Held
324MCall Options Held
260KPut Options Held
261K-
Vanguard Group Inc Valley Forge, PA28.6MShares$334 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$327 Million8.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$320 Million3.71% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$284 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA21.1MShares$246 Million0.04% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $3.27B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...